Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

Clinical Trials Search

As a clinical trial candidate at Methodist, you’re offered unique access to new drugs and technology being studied to improve patient outcomes.
Filter by Disease or Condition
Showing 1-10 results of 13
Lung Cancer

Alliance A081801

Official Title: Testing The Addition Of A Type Of Drug Called Immunotherapy To The Usual Chemotherapy Treatment For Non-Small Cell Lung Cancer
Study Purpose: To compare the usual treatment alone to using pembrolizumab plus the usual treatment.  The addition of pembrolizumab to the usual treatment could prevent it from returning.
Status: Recruiting
Lung Cancer

Alliance A151216

Official Title: Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Study Purpose: To study the genes of tumor cells to determine if these results will help physicians select the best treatment options for patients with genetic changes. 
Status: Recruiting
Lung Cancer

CTSU E4512

Official Title: A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Study Purpose: To compare any good and bad effects of using the study drug, crizotinib, after completion of surgery and, in some cases, after chemotherapy and/or radiation therapy for ALK-positive non-small cell lung cancer.
Status: Recruiting
Lung Cancer

CTSU LungMap

Official Title: Targeted Treatment for Advanced Non-small Cell Lung Cancer
Study Purpose: To find out if a targeted or immunotherapy treatment will have an effect on specific genes and proteins in the tumor.
Status: Recruiting
Lung Cancer

CTSU S1827

Official Title: Testing Whether the Of Brain Scans Alone Instead Of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients with Small Cell Lung Cancer
Study Purpose: To see if the use of brain scans alone instead of brain scans plus preventive brain radiation affect the lifespan of patients with small cell lung cancer.
Status: Recruiting
Lung Cancer

ECOG-ACRIN EA5162

Official Title: Phase II Study of Osimertinib in Advanced NSCLC Patients with Exon 20 Mutations in EGFR
Study Purpose: To evaluate the best objective response rate of AZD9291 (osimertinib) among patients with EGFR exon 20 insertions.
Status: Recruiting
Lung Cancer

ECOG-ACRIN EA5163

Official Title: A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature-Driven Analysis
Study Purpose: To find out whether either of these two usual approaches to treating this type of cancer is better or worse than the other.
Status: Recruiting
Lung Cancer

ECOG-ACRIN EA5181

Official Title: Testing The Addition Of An Antibody To Standard Chemoradiation Followed By The Antibody For One Year To Standard Chemoradiation Followed By One Year Of The Antibody In Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Study Purpose: To see if we can extend your life and/or prevent your tumor from coming back by adding a study drug durvalumab during chemotherapy and radiation therapy.
Status: Recruiting
Lung Cancer

ECOG-ACRIN EA5191

Official Title: Testing the Addition of the Pill Chemotherapy, Cabozantinib, To the Standard Immune Therapy Nivolumab Compared To Standard Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer
Study Purpose: To compare the two investigational treatments (cabozantinib alone to using cabozantinib plus the usual treatment nivolumab) to the current standard of care second line therapy
Status: Recruiting
Lung Cancer

NRG LU007

Official Title: Testing The Addition Of Radiation Therapy To The Usual Immune Therapy Treatment (Atezolizumab) For Patients With Extensive Stage Small Cell Lung Cancer
Study Purpose: To determine if can we extend the time without your extensive small cell lung cancer growing or spreading by adding radiation therapy to the usual treatment for this type of cancer.
Status: Recruiting